Literature DB >> 18342778

Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Yu-Waye Chu1, Ronald E Gress.   

Abstract

Chronic graft-versus-host-disease (cGVHD) is a major barrier to successful allogeneic hematopoietic stem cell transplantation (allo-HSCT), with highly variable clinical presentations. The pathophysiology of cGVHD remains relatively poorly understood. The utilization of murine models to study cGVHD encompasses experimental challenges distinct from those that have been successfully used to study acute GVHD (aGVHD). Nevertheless, despite these challenges, murine models of cGVHD have contributed to the understanding of cGVHD, and highlight its mechanistic complexity. In this article, insights into the pathophysiology of cGVHD obtained from murine studies are summarized in the context of their relevancy to clinical cGVHD. Despite experimental limitations, current and future models of murine cGVHD will continue to provide insights into the understanding of clinical cGVHD and provide information for new therapeutic interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18342778      PMCID: PMC2376050          DOI: 10.1016/j.bbmt.2007.12.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  116 in total

1.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.

Authors:  Lixin Zhou; David Askew; Caiyun Wu; Anita C Gilliam
Journal:  J Invest Dermatol       Date:  2006-08-17       Impact factor: 8.551

3.  Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.

Authors:  Mathias M Hauri-Hohl; Marcel P Keller; Jason Gill; Katrin Hafen; Esther Pachlatko; Thomas Boulay; Annick Peter; Georg A Holländer; Werner Krenger
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

Review 4.  Chronic graft-versus-host disease in the era of reduced-intensity conditioning.

Authors:  D S Subramaniam; D H Fowler; S Z Pavletic
Journal:  Leukemia       Date:  2007-03-22       Impact factor: 11.528

5.  Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus.

Authors:  Thomas Grader-Beck; Livia Casciola-Rosen; Thomas J Lang; Roman Puliaev; Antony Rosen; Charles S Via
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.

Authors:  Michael P Keane; Brigitte N Gomperts; Samuel Weigt; Ying Ying Xue; Marie D Burdick; Hiromi Nakamura; David A Zisman; Abbas Ardehali; Rajan Saggar; Joseph P Lynch; Cory Hogaboam; Steven L Kunkel; Nicholas W Lukacs; David J Ross; Michael J Grusby; Robert M Strieter; John A Belperio
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.

Authors:  Yukimi Sakoda; Daigo Hashimoto; Shoji Asakura; Kengo Takeuchi; Mine Harada; Mitsune Tanimoto; Takanori Teshima
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

8.  Chronic GvHD decreases antiviral immune responses in allogeneic BMT.

Authors:  Mohammad S Hossain; John D Roback; Brian P Pollack; David L Jaye; Amelia Langston; Edmund K Waller
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

9.  CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.

Authors:  Yi Zhang; Elizabeth Hexner; Dale Frank; Stephen G Emerson
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

10.  Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

Authors:  Silvia Svegliati; Attilio Olivieri; Nadia Campelli; Michele Luchetti; Antonella Poloni; Silvia Trappolini; Gianluca Moroncini; Andrea Bacigalupo; Pietro Leoni; Enrico V Avvedimento; Armando Gabrielli
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

View more
  58 in total

1.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  B-cell-directed therapy for chronic graft-versus-host disease.

Authors:  Caron A Jacobson; Jerome Ritz
Journal:  Haematologica       Date:  2010-11       Impact factor: 9.941

3.  Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.

Authors:  James S Young; Tao Wu; Yuhong Chen; Dongchang Zhao; Hongjun Liu; Tangsheng Yi; Heather Johnston; Jeremy Racine; Xiaofan Li; Audrey Wang; Ivan Todorov; Defu Zeng
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

Review 4.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

5.  Mouse Models of Skin Fibrosis.

Authors:  Aleix Rius Rigau; Markus Luber; Jörg H W Distler
Journal:  Methods Mol Biol       Date:  2021

6.  Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Authors:  Linda M Griffith; Steven Z Pavletic; Stephanie J Lee; Paul J Martin; Kirk R Schultz; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

7.  Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion.

Authors:  James W Hart; Lisa H Shiue; Elizabeth J Shpall; Amin M Alousi
Journal:  Ther Adv Hematol       Date:  2013-10

8.  Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model.

Authors:  Florence Morin; Niloufar Kavian; Wioleta Marut; Christiane Chéreau; Olivier Cerles; Philippe Grange; Bernard Weill; Carole Nicco; Frédéric Batteux
Journal:  J Invest Dermatol       Date:  2015-05-04       Impact factor: 8.551

Review 9.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

10.  Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant.

Authors:  Zachariah McIver; Jan Joseph Melenhorst; Colin Wu; Andrew Grim; Sawa Ito; Irene Cho; Nancy Hensel; Minoo Battiwalla; Austin John Barrett
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.